brequinar has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dallaire, B; Gyves, J; Maroun, J; Moore, M; Natale, R; Neidhart, J; Robert, F; Sisk, R | 1 |
| Cavalli, F; Dodion, PF; Drozd, A; Lev, LM; Renard, J; Skovsgaard, T; Stoter, G; Wagener, T | 1 |
1 trial(s) available for brequinar and Colorectal Cancer
| Article | Year |
|---|---|
Multicenter phase II study of brequinar sodium in patients with advanced gastrointestinal cancer.
Topics: Adult; Aged; Antineoplastic Agents; Biphenyl Compounds; Colorectal Neoplasms; Drugs, Investigational; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms | 1993 |
1 other study(ies) available for brequinar and Colorectal Cancer
| Article | Year |
|---|---|
Phase II trial with Brequinar (DUP-785, NSC 368390) in patients with metastatic colorectal cancer: a study of the Early Clinical Trials Group of the EORTC.
Topics: Adenocarcinoma; Adult; Animals; Antineoplastic Agents; Biphenyl Compounds; Colorectal Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged | 1990 |